VIR as of Oct 31 · 06:06 ET

VIRNasdaqBiological Products, (No Diagnostic Substances)

Vir Biotechnology, Inc. · Brief

Next report

4 days

Nov 4 · after closeest.Q3 FY26

Earnings

Expected move

Inputs

±11.5%implied · straddle

10.0012.60

spot 11.30exp Nov 20ATM strike 11ATM straddle 1.52IV 71%

Oct 30 close

Expected move

Inputs

Implied vs realized

8 reportsHistory

2 of 8≥ implied

avg implied: ±15.3%
avg realized: ±9.7%

Feb 26 '25±17.3%▼−11.85%×0.69

May 7 '25±13.3%▼−3.57%×0.27

Aug 6 '25±8.8%▼−14.37%×1.63

Q3 FY25±18.4%▼−5.19%×0.28

Jan 12 '26±12.2%▲+1.20%×0.10

Feb 23 '26±26.6%▲+27.73%×1.04

Q1 FY26±13.9%▼−9.91%×0.71

Q2 FY26±11.6%▼−3.79%×0.33

quarterimplied−30%0+30%realized×

Q2 FY26±11.6%▼−3.79%×0.33

Q1 FY26±13.9%▼−9.91%×0.71

Feb '26±26.6%▲+27.73%×1.04

Jan '26±12.2%▲+1.20%×0.10

Q3 FY25±18.4%▼−5.19%×0.28

Aug '25±8.8%▼−14.37%×1.63

2 older reports

May '25±13.3%▼−3.57%×0.27

Feb '25±17.3%▼−11.85%×0.69

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 4 report · est.

Bull2 of 3

8disclosed supplier and customer ties in SEC filingsSEC filings

237managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 4

6 of 8recent reports where the move came in under the options implied rangeEarnings history

9 of 25of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

VIR report session

Suppliers 1

XNCRXencor×0.31

× = co-movement · max 500dSource: SEC filings · market data

Latest changes

30 daysAll changes

Oct 21impliedImplied move: ±16.8% into Nov 4 earnings (Oct 21 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.